Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Real-time PCR (qPCR) and Digital PCR (dPCR) Market 2017: Key Players are Thermo Fisher, Bio-Rad Labs, Qiagen, Abbott & Cepheid - Research and Markets

Research and Markets
Posted on: 06 Oct 17

The "Real-time PCR (qPCR) andDigital PCR (dPCR) Market Analysis by Technology, by Product (Consumables & Reagents, Instruments, Software & Services), by Application and Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

The global real time PCR (qPCR) and digital PCR (dPCR) market is expected to reach USD 6.3 billion by 2025. Implementation of Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) and Real-time PCR Data Markup Language (RDML) guidelines that ensure high-quality results is estimated to provide the market with high growth opportunities.

In addition, increasing number of research & forensic laboratories and CROs is a key factor responsible for market growth. Laboratories and CROs use qPCR and dPCR techniques for gene-based, protein-based, and various other research applications owing to its high accuracy and sensitivity.

Increasing preference of PCR techniques in prenatal genetic testing and its associated advantages in prenatal genetic testing such as lack of need for reference standards, low cycle times, and reproducible results are some of the drivers expected to propel growth.

Furthermore, major players are in the process of acquiring companies manufacturing diagnostic devices for the development of technologically advanced qPCR and dPCR products. For instance, Bio-Rad laboratories acquired RainDance Technologies to strengthen their position in the area of digital PCR.

  • Some of the key players including Thermo Fisher Scientific Inc.; Bio-Rad Laboratories; QIAGEN; Abbott; and Cepheid dominated the global qPCR and dPCR market in 2016.

Companies Mentioned

  • Affymetrix, Inc.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen N.V.
  • Abbott Laboratories, Inc.
  • Cepheid
  • Agilent Technologies, Inc.
  • GE Healthcare
  • biomrieux S.A.
  • Hoffman-La Roche
  • Fluidigm Corporation

Key Topics Covered:

Chapter 1 Research Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Real Time PCR (qPCR) & Digital PCR (dPCR) Market Variables, Trends & Scope

Chapter 4 Real Time PCR (qPCR) & Digital PCR (dPCR): Technology Estimates & Trend Analysis

Chapter 5 Real Time PCR (qPCR) & Digital PCR (dPCR): Product & Services & Trend Analysis

Chapter 6 Real Time PCR (qPCR) & Digital PCR (dPCR): Application Estimates & Trend Analysis

Chapter 7 Real Time PCR (qPCR) & Digital PCR (dPCR): Regional Estimates & Trend Analysis, by Application

Chapter 8 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/s27j56/realtime_pcr

View source version on businesswire.com: http://www.businesswire.com/news/home/20171006005281/en/

Business Wire
www.businesswire.com

Last updated on: 06/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.